18 hours ago
1
Max Zolotukhin/iStock via Getty Images
Sarepta Therapeutics (NASDAQ:SRPT) has hired a lobbying firm with close ties to the Trump administration as regulatory scrutiny intensified after two young males who received its gene therapy Elevidys died early this year, according to investigative journalist Lee Fang.
The
English (US) ·